The Centre for Infectious Disease Research in Zambia (CIDRZ) is an independent NGO dedicated to enhancing healthcare access in Zambia through innovative capacity development, implementation science, and impactful public health programs. CIDRZ collaborates closely with the Zambian government and partners with local and international institutions to ensure high-quality, integrated healthcare and research. Over two decades, CIDRZ has expanded from an HIV focus to address a broad range of infectious diseases and global health threats, while also supporting the development of Zambian scientists through fellowship programs and research initiatives.
Vision
A Zambia, and a region, in which all people have access to quality healthcare and enjoy the best possible health.
Mission
To improve access to quality healthcare in Zambia through innovative capacity development, exceptional implementation science and research, and impactful and sustainable public health programmes.
Core Values
Accountability: Our staff members embody ownership and embrace accountability for their contributions and decisions.
Equality: CIDRZ fosters a culture of fairness and equal opportunity.
Honesty: Our staff members consistently uphold integrity and transparency in all their activities.
Productivity: Our team strives for excellence and consistently delivers high-quality results.
Respect: We nurture a workplace culture where all individuals, including partners and stakeholders, are valued and their differences are celebrated.
Transparency: Our organization embraces open communication and fosters an environment for constructive, open, and honest problem solving.
Based on Zambia's National Health Research priority agenda, CIDRZ aims to identify and implement locally relevant, culturally acceptable, and evidence-based interventions to influence policy formulation. To support evidence-based policy decisions, CIDRZ conducts a variety of research studies, including clinical trials, surveys, and behavioral and implementation science studies, primarily within public clinical care facilities in Lusaka, all endorsed by the Ministry of Health and subject to ongoing ethical review. Recognizing the importance of ethical standards in human research, CIDRZ’s Research Operations department ensures compliance with international and national regulations, including ICH-GCP guidelines and CFR Title 45 Part 46, by thoroughly reviewing all trial applications, protocol amendments, and adverse event reports. For over 10 years, this department has maintained up-to-date knowledge of regulations, ensuring that all research activities meet the highest ethical standards.
Click Here To Read More.
CIDRZ leadership is comprised of dedicated and experienced professionals with competencies in medicine, public health, finance, operations, biomedical science, human resources, information technology and compliance.
CIDRZ runs a state-of-the-art Medical Diagnostic and Research Laboratory in Kalingalinga area of Lusaka, The laboratory supports research activities and provides medical diagnostic services to individual clients and projects by performing a wide range of assays in the following disciplines:
-
Haematology
-
Clinical Chemistry
-
Immunochemistry
-
Serology
-
Molecular Biology
-
Microbiology
As the Central Laboratory, the CIDRZ lab prides itself on delivering high-quality results to clients, supported by a robust Quality Management System that has earned it ISO 15189 accreditation. This International Standard ensures quality and competency in medical laboratories, and the accreditation was granted by the Southern African Development Community Accreditation Services (SADCAS) after a thorough review. The CIDRZ lab is also accredited in various disciplines, including Haematology, Microbiology, Serology, Molecular Biology, and Clinical Chemistry. The lab is regularly audited by the National Health Institute Division of AIDS (DAIDS) through the National Institute of Allergy and Infectious Diseases (NIAID) Research support services to maintain our high standards of competency.
Click Here To Read More.